Skip to main content
. 2024 Jun 10;17(3):e004369. doi: 10.1161/CIRCGEN.123.004369

Figure 4.

Figure 4.

Comprehensive overview of alterations in energy metabolism and lipid-handling pathways in patients with hypertrophic cardiomyopathy (HCM) vs nonfailing (NF) donors integrating metabolomics, lipidomics, and proteomics data. Metabolomic, lipidomic, and proteomic data were integrated to provide an overview of changes in major energy metabolism and lipid-handling pathways. Metabolites and lipids are indicated by objects with a dark fill and white text; proteins are indicated by objects with a light fill and black text. Blue, orange, and gray indicate lower, higher, and unchanged abundances in HCM vs NF donors, respectively. Created with BioRender.com.